|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.600 USD | -5.26% |
|
+2.71% | -0.28% |
| 03-12 | Altimmune, Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-12-2026 10:30 AM | |
| 03-06 | B. Riley Adjusts Price Target on Altimmune to $13 From $18, Maintains Buy Rating | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALTIMMUNE, INC. | Bio Therapeutic Drugs | -5.26% | +2.71% | -0.28% | -35.14% | -78.52% | 468M |  | |  |
- Stock Market
- Equities
- ALT Stock
- Charts Altimmune, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition